Related Experiment Video

Updated: Jul 15, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Loss-of-function JAK3 mutations in TMD and AMKL of Down syndrome

Serena De Vita1, Claire Mulligan, Suzanne McElwaine

  • 1Centre for Haematology, Institute of Cell and Molecular Science, Barts & The London, Queen Mary's School of Medicine, University of London, London, UK.

British Journal of Haematology
|April 26, 2007
PubMed

Insights

Acquired Janus kinase 3 (JAK3) mutations are implicated in acute megakaryoblastic leukemia (AMKL), even in Down syndrome (DS) cases. Both activating and inactivating JAK3 mutations were observed in DS-transient myeloproliferative disorder/AMKL patients.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Acquired Janus kinase 3 (JAK3) mutations are linked to acute megakaryoblastic leukemia (AMKL) in both Down syndrome (DS) and non-DS patients.
  • JAK3 activation is recognized as a key factor in AMKL pathogenesis, suggesting JAK3 inhibitors as potential therapies.

Purpose of the Study:

  • To investigate the spectrum of JAK3 mutations in patients with DS-associated transient myeloproliferative disorder (TMD) and AMKL.
  • To determine if both gain-of-function and loss-of-function JAK3 mutations occur in this patient cohort.

Main Methods:

  • Genetic analysis of JAK3 in a cohort of 16 DS-TMD/AMKL patients.
  • Characterization of identified JAK3 mutations, including their impact on kinase function.

Main Results:

  • Seven out of 16 DS-TMD/AMKL patients harbored JAK3 mutations.
  • Three mutations resulted in the deletion of the kinase (JH1) domain, leading to loss of JAK3 function.
  • One patient presented with a mutation previously associated with inherited loss-of-function and severe combined immunodeficiency.

Conclusions:

  • Both gain-of-function and loss-of-function mutations in JAK3 can be acquired in the context of DS-TMD/AMKL.
  • These findings expand the understanding of JAK3's role in the development of AMKL, particularly in DS patients.

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...